ANTXR1 and gastric cancer: Similarly, TEM8 was described as a new biomarker in pancreatic cancer (Alcalá et al., 2019) and for gastric cancer, in which it was suggested as a prognostic biomarker due to its relationship with the immune and stromal scores as well as correlation between high expression with clinicopathological parameters (Huang et al., 2020; Cai, et al., 2020).